Executive summary of the guidelines for the use of interferon-gamma release assays in the diagnosis of tuberculosis infection
Por:
Santin, M, Garcia-Garcia, JM, Rigau, D, Altet, N, Anibarro, L, Casas, I, Diez, N, Garcia-Gasalla, M, Martinez-Lacasa, X, Penas, A, Perez-Escolano, E, Sanchez, F, Dominguez, J
Publicada:
1 may 2016
Resumen:
Interferon-gamma release assays are widely used for the diagnosis of tuberculosis infection in Spain. However, there is no consensus on their application in specific clinical scenarios. To develop a guideline for their use, a panel of experts comprising specialists in infectious diseases, respiratory diseases, microbiology, pediatrics and preventive medicine, together with a methodologist, conducted a systematic literature search, summarized the findings, rated the quality of the evidence, and formulated recommendations following the GRADE (Grading of Recommendations of Assessment Development and Evaluations) methodology. This document provides evidence-based guidance on the use of interferon-gamma release assays for the diagnosis of tuberculosis infection in patients at the risk of tuberculosis or suspected of having active disease. The guidelines will be applicable to specialist and primary care, and public health. (C) 2016 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
|